BIOE
DEAD

Serial Number

88577146

Owner

Truetiva, Inc.

Attorney

Curtis Wadworth, J.D., Ph.D.

First Use Date

Mar 15, 2019

Filing Date

Aug 13, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BIOE Trademark

Serial Number: 88577146

BIOE is a trademark filed by Truetiva, Inc. on August 13, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Truetiva, Inc. (3 trademarks)

7 Monroe Cneter NE
Grand Rapids, MI 49503

Entity Type: 03

Trademark Details

Filing Date

August 13, 2019

Registration Date

Not Registered

First Use Anywhere

March 15, 2019

First Use in Commerce

March 15, 2019

Goods & Services

Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, lipid lowering agents; Balms for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Plant extracts for pharmaceutical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 24, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 23, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 23, 2022 ABN2
ASSIGNED TO EXAMINER
Aug 17, 2022 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 10, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 10, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 10, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 14, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 6, 2020 DOCK
ASSIGNED TO EXAMINER
Nov 12, 2019 DOCK
ASSIGNED TO EXAMINER
Nov 12, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2019 NWOS
NEW APPLICATION ENTERED
Aug 16, 2019 NWAP